We investigated mechanism of resistance to both faslodex and tamoxifen in a panel of 14 ER+ breast cancers cell lines. Growth inhibition assays indicated that some cell lines in the panel are significantly more sensitive to faslodex than to tamoxifen while other cell lines are e…
"2" Result
Sort By: